Literature DB >> 34185075

Vitamin D Levels May Predict Response to Vedolizumab.

Giorgos Bamias1, Jesús Rivera-Nieves2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34185075      PMCID： PMC8684447          DOI： 10.1093/ecco-jcc/jjab105

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   10.020


× No keyword cloud information.
  8 in total

1.  Role of Vitamin D in Infliximab-induced Remission in Adult Patients with Crohn's Disease.

Authors:  Krista M Reich; Richard N Fedorak; Karen Madsen; Karen I Kroeker
Journal:  Inflamm Bowel Dis       Date:  2016-01       Impact factor: 5.325

2.  Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease.

Authors:  Sebastian Zeissig; Elisa Rosati; C Marie Dowds; Konrad Aden; Philip C Rosenstiel; Andre Franke; Stefan Schreiber; Johannes Bethge; Berenice Schulte; Wei Hung Pan; Neha Mishra; Maaz Zuhayra; Marlies Marx; Maren Paulsen; Anne Strigli; Claudio Conrad; Dörthe Schuldt; Anupam Sinha; Henriette Ebsen; Sabin-Christin Kornell; Susanna Nikolaus; Alexander Arlt; Dieter Kabelitz; Mark Ellrichmann; Ulf Lützen
Journal:  Gut       Date:  2018-05-05       Impact factor: 23.059

3.  DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27.

Authors:  Hekla Sigmundsdottir; Junliang Pan; Gudrun F Debes; Carsten Alt; Aida Habtezion; Dulce Soler; Eugene C Butcher
Journal:  Nat Immunol       Date:  2007-01-28       Impact factor: 25.606

Review 4.  Role of Vitamin D in the Natural History of Inflammatory Bowel Disease.

Authors:  Ole Haagen Nielsen; Lars Rejnmark; Alan C Moss
Journal:  J Crohns Colitis       Date:  2018-05-25       Impact factor: 9.071

5.  Functional Molecular Network Analysis Enables Prediction of Response to Vedolizumab Therapy in Anti-TNF Refractory IBD Patients.

Authors:  Matthias Breidert; Pierre Eftekhari; François Louis; Claudia Rotoiu; Timo Rath; Markus F Neurath; Raja Atreya
Journal:  Crohns Colitis 360       Date:  2020-05-24

6.  Pretreatment 25-hydroxyvitamin D levels and durability of anti-tumor necrosis factor-α therapy in inflammatory bowel diseases.

Authors:  Zachary A Zator; Stephanie M Cantu; Gauree Gupta Konijeti; Deanna D Nguyen; Jenny Sauk; Vijay Yajnik; Ashwin N Ananthakrishnan
Journal:  JPEN J Parenter Enteral Nutr       Date:  2013-10-02       Impact factor: 4.016

7.  Expression Levels of 4 Genes in Colon Tissue Might Be Used to Predict Which Patients Will Enter Endoscopic Remission After Vedolizumab Therapy for Inflammatory Bowel Diseases.

Authors:  Bram Verstockt; Sare Verstockt; Marisol Veny; Jonas Dehairs; Kaline Arnauts; Gert Van Assche; Gert De Hertogh; Séverine Vermeire; Azucena Salas; Marc Ferrante
Journal:  Clin Gastroenterol Hepatol       Date:  2019-08-22       Impact factor: 11.382

Review 8.  Managing vitamin D deficiency in inflammatory bowel disease.

Authors:  Ole Haagen Nielsen; Thomas Irgens Hansen; John Mark Gubatan; Kim Bak Jensen; Lars Rejnmark
Journal:  Frontline Gastroenterol       Date:  2019-01-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.